TS Financial Group (TSFG)’s Charles River Laboratories CRL Stock Holding History

TS Financial Group (TSFG)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8	Closed	-$2K	–	789
2024 Q2	$2K	Sell	8 -142	-95%	-$32.2K	﹤0.01%	660
2024 Q1	$41K	Hold	150	–	–	0.01%	294
2023 Q4	$35K	Sell	150 -8	-5%	-$1.57K	0.01%	332
2023 Q3	$31K	Hold	158	–	–	0.01%	361
2023 Q2	$33K	Buy	158 +52	+49%	+$10.3K	0.01%	348
2023 Q1	$21K	Hold	106	–	–	0.01%	399
2022 Q4	$23K	Hold	106	–	–	0.01%	391
2022 Q3	$21K	Sell	106 -172	-62%	-$37.1K	0.01%	392
2022 Q2	$59K	Hold	278	–	–	0.03%	261
2022 Q1	$79K	Sell	278 -10	-3%	-$3.08K	0.03%	241
2021 Q4	$109K	Buy	288 +45	+19%	+$17.5K	0.04%	201
2021 Q3	$100K	Hold	243	–	–	0.04%	216
2021 Q2	$90K	Hold	243	–	–	0.04%	227
2021 Q1	$70K	Hold	243	–	–	0.04%	223
2020 Q4	$61K	Buy	+243	New	+$57.9K	0.03%	228

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

TS Financial Group (TSFG)'s CRL Position: Q3 2024 in Review

TS Financial Group (TSFG) sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 8 shares — an estimated $2K sold.

TS Financial Group (TSFG) first reported a position in CRL in Q4 2020 and held it in 15 quarters. The position peaked at $109K in Q4 2021. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

TS Financial Group (TSFG) reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
TS Financial Group (TSFG) sold 8 Charles River Laboratories shares in Q3 2024, an estimated $2K.
TS Financial Group (TSFG) first reported a position in Charles River Laboratories in Q4 2020 and held it in 15 quarters.
TS Financial Group (TSFG)'s Charles River Laboratories position peaked at $109K in Q4 2021.
628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on TS Financial Group (TSFG)'s 13F filing for Q3 2024, filed 15 Oct 2024.